RAPT
RAPT
NASDAQ · Biotechnology

Rapt Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$58.02
+0.04 (+0.07%)
As of May 30, 1:39 AM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 6 35%
Hold 11 65%
Sell 0 0%
Price Target
Analyst Price Target -54.6% upside
Low Target $18.77
Average Target $26.34
High Target $31.12
Current Price $58.02
Current
$58.02
Target
$26.34
$18.77 $26.34 avg $31.12
Scenario Analysis
Bear Case
$18.77
-67.6%
Low target
Base Case
$26.34
-54.6%
Avg target
Bull Case
$31.12
+-46.4%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$58.02
0.0% from high
52-Week Low
$6.88
+743.3% from low
Target vs 52W High
$26.34
-54.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -36.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.5%